DESTINY MOSS: Open Payments
NPI 1972997179 · SPARTANBURG, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,581 in 55 payments from 22 companies in 2025. Trend: 2023 $1,359 · 2024 $1,156 · 2025 $2,581
Travel & lodging: $1,320Food & beverage: $1,261
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 18 | $1,840 |
| ABBVIE INC. | 5 | $105 |
| Sumitomo Pharma America, Inc. | 4 | $64 |
| C. R. Bard, Inc. & Subsidiaries | 2 | $64 |
| UROGEN PHARMA, INC. | 2 | $60 |
| Ferring Pharmaceuticals Inc. | 3 | $59 |
| Endo USA, Inc. | 3 | $52 |
| Astellas Pharma US Inc | 2 | $40 |
| PROGENICS PHARMACEUTICALS, INC. | 2 | $32 |
| Antares Pharma, Inc. | 2 | $31 |
Products named: Axonics, BOTOX, GEMTESA, JELMYTO, Xtandi, ADSTILADRIN, AVEED, Magic3 Go Intermittent Urinary Catheter.
Industry payments across SC — which companies pay providers there.
